Beyond the target pathogen: ecological effects of the hospital formulary

被引:38
|
作者
Goldstein, Ellie J. C. [1 ]
机构
[1] David Geffen Sch Med UCLA, RM Alden Res Lab, Santa Monica, CA USA
关键词
carbapenem; Clostridium difficile infection; collateral damage; susceptibility breakpoint; CLOSTRIDIUM-DIFFICILE INFECTION; COMPARATIVE CLINICAL-TRIALS; HEALTH-CARE EPIDEMIOLOGY; ANTIBIOTIC-RESISTANCE; DISEASES-SOCIETY; UNITED-STATES; INTRAABDOMINAL INFECTIONS; ANTIMICROBIAL RESISTANCE; ERYTHROMYCIN RESISTANCE; PSEUDOMONAS-AERUGINOSA;
D O I
10.1097/01.qco.0000393485.17894.4c
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Purpose of review Antibiotic therapy has the potential for intended as well as unintended consequences due to ecological effects that extend beyond the target pathogen. This review examines some of the collateral damage and collateral benefit that may occur when using antibiotic therapy. Recent findings Antibiotics excreted in the gastrointestinal tract cause alterations of the indigenous flora. Such disruptions may increase the risk of colonization and overgrowth of pathogenic bacteria, including resistant species, with the potential for serious infection for an individual patient as well as possible hospital-wide dissemination resulting in local outbreaks of infection. For example, Clostridium difficile infection (CDI), and particularly associated diarrhea and colitis, is a potentially serious and growing problem in hospitals worldwide, and is associated with disruption of gut flora through use of broad-spectrum antibiotics, especially those with antianaerobic activity. Infection control measures and improved antibiotic stewardship are key measures for CDI prevention. Another example is the risk of intestinal colonization and overgrowth with resistant bacteria, which is heightened in surgical patients requiring antimicrobial therapy for intraabdominal infections. Results from two Optimizing Intra-Abdominal Surgery with Invanz studies (OASIS-I and OASIS-II) suggested emergence of resistant Enterobacteriaceae was less likely in these patients treated with ertapenem than in those treated with ceftriaxone/metronidazole or piperacillin/tazobactam. Finally, recent studies have reported that increased use of a nonpseudomonal carbapenem such as ertapenem does not reduce the susceptibility of Pseudomonas aeruginosa to pseudomonal carbapenems, for example, imipenem or meropenem. In fact, data from one study showed increased ertapenem/decreased imipenem use was associated with improved susceptibility of P. aeruginosa to imipenem, probably due to decreased selective pressure for resistant species. Summary Improper antibiotic use can be associated with detrimental effects related to the ecological impacts of these drugs. Improved antibiotic stewardship and appropriate infection control measures are key to minimization of the collateral damage associated with antibiotic therapy and may even have collateral benefits.
引用
收藏
页码:S21 / S31
页数:11
相关论文
共 50 条
  • [31] The Impact of Delisting Docusate from a Hospital Formulary
    McGuire, A.
    Wyllie, A.
    Fan-Lun, C.
    Mantas, I
    CANADIAN JOURNAL OF HOSPITAL PHARMACY, 2019, 72 (01): : 82 - 82
  • [32] PHARMACOECONOMIC IMPACT OF SUGAMMADEX ADDITION TO A HOSPITAL FORMULARY
    Blair, Mary
    Walroth, Todd
    Wickesberg, Christopher
    CRITICAL CARE MEDICINE, 2020, 48
  • [33] ORIGIN AND DEVELOPMENT OF AMERICAN HOSPITAL FORMULARY SERVICE
    FRANCKE, DE
    DRUG INTELLIGENCE & CLINICAL PHARMACY, 1972, 6 (12): : 448 - 456
  • [34] Closing formulary reduced CHF costs for hospital
    不详
    FORMULARY, 1995, 30 (12) : 762 - 762
  • [35] The effect of an antimicrobial formulary change on hospital resistance patterns
    Empey, KM
    Rapp, RP
    Evans, ME
    PHARMACOTHERAPY, 2002, 22 (01): : 81 - 87
  • [36] STRATEGIES FOR DELETING POPULAR DRUGS FROM A HOSPITAL FORMULARY
    LEMAY, AP
    SALZER, LB
    VISCONTI, JA
    LATIOLAIS, CJ
    AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1981, 38 (04): : 506 - 510
  • [37] SELECTION OF ANTICANCER DRUGS FOR INCLUSION IN MEMORIAL HOSPITAL FORMULARY
    KARNOFSKY, DA
    CLIFFORD, GO
    MEDICAL CLINICS OF NORTH AMERICA, 1966, 50 (03) : 857 - +
  • [38] EXPERIENCE WITH A DRUG FORMULARY IN A LARGE ITALIAN CITY HOSPITAL
    ZACCARA, A
    SIRTORI, CR
    MARCHESI, F
    PHARMACOLOGICAL RESEARCH, 1989, 21 (01) : 51 - 57
  • [39] The effect of formulary restriction in the use of antibiotics in an Italian hospital
    Matteo Bassetti
    Antonio Di Biagio
    Barbara Rebesco
    Maria Amalfitano
    Jeffrey Topal
    Dante Bassetti
    European Journal of Clinical Pharmacology, 2001, 57 : 529 - 534
  • [40] 15 YEARS OF "AMERICAN-HOSPITAL-FORMULARY-SERVICE
    PROVOST, GP
    AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1974, 31 (01): : 35 - 35